Canadian Adalimumab Postmarketing Observational Epidemiological Study Assessing Effectiveness in Psoriatic Arthritis (COMPLETE-PsA): 12-month Results of Comparative Effectiveness of Adalimumab and nbDMARDs-论文-万方医学网

Canadian Adalimumab Postmarketing Observational Epidemiological Study Assessing Effectiveness in Psoriatic Arthritis (COMPLETE-PsA): 12-month Results of Comparative Effectiveness of Adalimumab and nbDMARDs

导出原文传递

翻译打印收藏纠错

作者： Khraishi, Majed M. ^[1] ; Remple, Valencia P. ^[2] ; Silverberg, Samuel ^[3] ; Stewart, Jacqueline C. ^[4] ; Florica, Brandusa ^[5] ; Bessette, Louis ^[6]

作者单位： Mem Univ Newfoundland ^[1] AbbVie Biopharmaceut Sarl ^[2] Etobicoke Gen Hosp ^[3] Univ British Columbia ^[4] Univ Toronto ^[5] Ctr Hosp Univ Laval,Univ Laval ^[6]

关键词 disease-modifying antirheumatic drugs longitudinal studies nonsteroidal antiinflammatory drugs psoriatic arthritis LONG-TERM TREATMENT REAL-LIFE SAFETY EFFICACY THERAPY METHOTREXATE RESPONSES MODERATE PLACEBO SKIN

发布时间 2022-07-29

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

Canadian Adalimumab Postmarketing Observational Epidemiological Study Assessing Effectiveness in Psoriatic Arthritis (COMPLETE-PsA): 12-month Results of Comparative Effectiveness of Adalimumab and nbDMARDs

相似文献

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Canadian Adalimumab Postmarketing Observational Epidemiological Study Assessing Effectiveness in Psoriatic Arthritis (COMPLETE-PsA): 12-month Results of Comparative Effectiveness of Adalimumab and nbDMARDs

相似文献

相关期刊

检索历史清除